Erika M Gaglione
9PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Jan 08, 2025
Potentiating CD20 monoclonal antibody therapy by targeting complement C3 fragments covalently deposited on lymphoma cells.Sivasubramanian Baskar, Haiyong Peng, Erika M Gaglione
|May 25, 2023
CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy.Anfal Alsadhan, Jonathan Chen, Erika M Gaglione
|May 23, 2023
Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting.Maissa Mhibik, Erika M Gaglione, David Eik
|Nov 14, 2022
NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts.Deyi Zhang, Hailey M Harris, Jonathan Chen
|Nov 15, 2021
Overcoming Acquired Epigenetic Resistance to BTK Inhibitors.Arthur L Shaffer, James D Phelan, James Q Wang
|Apr 20, 2021
Select Antitumor Cytotoxic CD8+ T Clonotypes Expand in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib.Maria Joao Baptista, Sivasubramanian Baskar, Erika M Gaglione
Pageof 2
Frequent Collaborators
6 joint publications
Clare Sun
4 joint publications
Inhye E Ahn
2 joint publications
Adrian Wiestner
2 joint publications
Jonathan Chen
2 joint publications
Xin Tian
2 joint publications
Chingiz Underbayev
2 joint publications
Anfal Alsadhan
1 joint publications
Constance M Yuan
1 joint publications
Deyi Zhang
1 joint publications
Jen Judy
